Anti-LFA1 monoclonal antibody (25.3) for
โ
A. M. Stoppa; D. Maraninchi; D. Blaise; P. Viens; M. Hirn; D. Olive; J. Reiffers
๐
Article
๐
1991
๐
Springer
๐
English
โ 537 KB
The in vivo efficacy of 25.3 monoclonal antibody (mAb) directed against human LFA1 molecule was assessed in ten patients with steroid-resistant grade III-IV acute graft-versus-host disease (AGVHD). These patients received non-T-cell-depleted allogeneic bone marrow transplantation for aplastic anemia